Rate this Article: Comparative Analysis of Pharmacokinetic Properties of the FDA-Approved Ovarian, Fallopian Tube, and Primary Peritoneal Cancer Drugs

Rating (1-10):

5

Comments (SR21930175626): Full Name: Email Address:

Back to Article